Option Care(US:OPCH) Globenewswire·2025-10-30 11:00Core Insights - Option Care Health reported strong financial results for Q3 2025, with balanced growth across its service portfolio [2][6] - The company is well-positioned to navigate a dynamic regulatory environment and changing competitive landscape while focusing on patient care [2] Financial Performance - Net revenue reached $1,435.0 million, reflecting a year-over-year increase of 12.2% [6] - Gross profit was $272.9 million, up 6.3% from the previous year [6] - Net income decreased to $51.8 million, down 3.8% year-over-year [6] - GAAP diluted earnings per share increased to $0.32, up 3.2% [6] - Adjusted EBITDA was $119.5 million, an increase of 3.4% [6] - Adjusted diluted earnings per share rose to $0.45, up 9.8% [6] Updated Financial Guidance - For the full year 2025, the company expects net revenue between $5.60 billion and $5.65 billion [7] - Adjusted diluted earnings per share is projected to be between $1.68 and $1.72 [7] - Adjusted EBITDA is anticipated to be between $468 million and $473 million [7] - Cash flow from operations is expected to be at least $320 million [7] Operational Highlights - The company has over 8,000 team members, including more than 5,000 clinicians, providing infusion services across all 50 states [4] - Option Care Health is focused on elevating standards of care for patients with both acute and chronic conditions [4] Stock and Debt Management - The company repurchased $62.5 million of its stock during the quarter [6] - A term loan was expanded by $49.6 million, with a reduction in the interest rate [6]